ARCHIVES

Clinical Research Needs Payment Mechanism, Kerrey

This article is from The Cancer Letter archive.

Vol. 20 No. 05 | February 4, 1994

Download PDF Visit The Full Archive

Related Articles

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999